SEC-sourced researchBeta
ABT
ABBOTT LABORATORIES
Company comparison ↗
Data passport
- CIK
- 0000001800
- Exchange
- NYSE
- Business activity
- — · SIC 2834
- Financial inputs
- 5/6
- Filing date
- Oct 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 40,109,000,000.0000 | Feb 20, 2026 |
| December 2024 | 41,950,000,000.0000 | Feb 20, 2026 |
| December 2025 | 44,328,000,000.0000 | Feb 20, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 44,328,000,000.0000 | 6,524,000,000.0000 | 9,566,000,000.0000 | 86,713,000,000.0000 | — | Feb 20, 2026 |
| December 2024 | 41,950,000,000.0000 | 13,402,000,000.0000 | 8,558,000,000.0000 | 81,414,000,000.0000 | — | Feb 20, 2026 |
| December 2023 | 40,109,000,000.0000 | 5,723,000,000.0000 | 7,261,000,000.0000 | — | — | Feb 20, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $44.33B | December 2025 | Feb 20, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $41.95B | December 2024 | Feb 20, 2026 | 10-K |
| Net incomeNetIncomeLoss | $6.52B | December 2025 | Feb 20, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $9.57B | December 2025 | Feb 20, 2026 | 10-K |
| Total assetsAssets | $86.71B | December 2025 | Feb 20, 2026 | 10-K |
| Total liabilities | — | — | — | — |
New filings
- 4ABT · ABBOTT LABORATORIESOct 2, 2026 · Other
- 4ABT · ABBOTT LABORATORIESOct 2, 2026 · Other
- 4ABT · ABBOTT LABORATORIESOct 2, 2026 · Other
- 4ABT · ABBOTT LABORATORIESOct 2, 2026 · Other
- 4ABT · ABBOTT LABORATORIESOct 2, 2026 · Other
- 4ABT · ABBOTT LABORATORIESSep 25, 2026 · Other
- 4ABT · ABBOTT LABORATORIESSep 3, 2026 · Other
- 4ABT · ABBOTT LABORATORIESSep 3, 2026 · Other
- 144ABT · ABBOTT LABORATORIESSep 2, 2026 · Other
- 4ABT · ABBOTT LABORATORIESAug 27, 2026 · Other
- 10-KABT · ABBOTT LABORATORIESFeb 20, 2026 · Annual